Analysis of Central Automotive Products Ltd. (8117)
Central Automotive Products Ltd. (symbol: 8117) has been experiencing some fluctuations in its stock price recently. The RSI indicator shows that the stock is currently in the oversold territory, indicating a possible buying opportunity. However, the MACD indicator is negative, suggesting a bearish trend in the short term.
Looking at the moving averages, the stock price is below the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA). This indicates a downward trend in the stock price.
Overall, Central Automotive Products Ltd. seems to be facing some selling pressure based on the technical indicators. Investors may want to exercise caution and closely monitor the stock before making any investment decisions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are both healthy, and the company shows good returns on assets and equity. The fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Moving on to stock statistics, we see details such as short ratio, float shares, shares outstanding, and percentages held by insiders and institutions. The company's stock has been trading at certain volumes, with a small percentage of shares being held short.
Valuation metrics show metrics like PEG ratio, PE ratios, enterprise value, price to book, and price to sales ratios. The market capitalization is also provided, giving an indication of the company's overall value in the market.
The stock price summary includes information on beta, moving averages, and the range of stock prices over the past year.
Lastly, dividends and splits data show details on payout ratio, dividend dates, split dates, and dividend yields. The company has a history of dividends and splits, with both forward and trailing dividend rates and yields being provided.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing steadily over the past four fiscal years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the net income has also shown a positive trend, rising from $57.4 billion in 2020 to $97 billion in 2023.
3. The company has been able to maintain a healthy EBITDA margin, with values ranging from $81 billion to $129 billion over the four-year period.
4. The basic and diluted earnings per share (EPS) have remained relatively stable, with slight fluctuations over the years.
5. Operating income has also shown a positive trend, increasing from $66.3 billion in 2020 to $114.3 billion in 2023.
6. The company has managed its operating expenses effectively, with a slight increase in research and development costs but relatively stable selling, general, and administrative expenses.
7. Overall, the financial performance of the company, as indicated by its revenues, net income, and operating income, has been on an upward trajectory over the past four years.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, with the highest value in 2023 at $143.6 billion.
3. Non-current assets have also shown an increasing trend, reaching $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $248 billion in 2019 to $290.4 billion in 2023.
5. Shareholders' equity has shown an increasing trend, with fluctuations, reaching $62.1 billion in 2023.
6. The company has been investing more in non-current assets over the years, indicating potential long-term growth strategies.
7. The company has been relying more on long-term debt to finance its operations, as seen in the increasing trend of non-current liabilities.
8. The company has managed to maintain a positive shareholders' equity throughout the years, indicating a healthy financial position.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests further growth compared to the EPS of $6.10 for the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and the next fiscal years.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate to healthy growth expected in both the short term and the long term.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slight slowdown compared to the past 5 years but still showing healthy growth prospects in the near future.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security, with a median and average price above the current price. However, there is a wide range between the low and high forecasts, indicating some uncertainty in the predictions.MACD of 8117